Skip to content
10-K/A

Annual Report

MERRIMACK PHARMACEUTICALS INC

0001193125-24-073929

← back to feed
Filed
Mar 21, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 15, 2024 14.53M sh